nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—HTR3A—Memantine—Alzheimer's disease	0.289	0.524	CbGbCtD
Dolasetron—CYP2D6—Alzheimer's disease	0.271	1	CbGaD
Dolasetron—CYP2D6—Rivastigmine—Alzheimer's disease	0.0564	0.102	CbGbCtD
Dolasetron—CYP2C9—Donepezil—Alzheimer's disease	0.0493	0.0893	CbGbCtD
Dolasetron—CYP2D6—Donepezil—Alzheimer's disease	0.0451	0.0816	CbGbCtD
Dolasetron—CYP3A4—Rivastigmine—Alzheimer's disease	0.0359	0.0649	CbGbCtD
Dolasetron—CYP2D6—Galantamine—Alzheimer's disease	0.0291	0.0526	CbGbCtD
Dolasetron—CYP3A4—Donepezil—Alzheimer's disease	0.0287	0.0519	CbGbCtD
Dolasetron—CYP3A4—Galantamine—Alzheimer's disease	0.0185	0.0335	CbGbCtD
Dolasetron—Dehydration—Memantine—Alzheimer's disease	0.000423	0.00243	CcSEcCtD
Dolasetron—Sweating increased—Donepezil—Alzheimer's disease	0.000421	0.00242	CcSEcCtD
Dolasetron—Ataxia—Rivastigmine—Alzheimer's disease	0.000418	0.0024	CcSEcCtD
Dolasetron—Tinnitus—Galantamine—Alzheimer's disease	0.000417	0.0024	CcSEcCtD
Dolasetron—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000415	0.00239	CcSEcCtD
Dolasetron—Flushing—Galantamine—Alzheimer's disease	0.000415	0.00239	CcSEcCtD
Dolasetron—Dehydration—Rivastigmine—Alzheimer's disease	0.000414	0.00238	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000409	0.00235	CcSEcCtD
Dolasetron—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000406	0.00234	CcSEcCtD
Dolasetron—Dysuria—Donepezil—Alzheimer's disease	0.000405	0.00233	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000401	0.00231	CcSEcCtD
Dolasetron—Arrhythmia—Galantamine—Alzheimer's disease	0.000399	0.0023	CcSEcCtD
Dolasetron—Pneumonia—Donepezil—Alzheimer's disease	0.000388	0.00223	CcSEcCtD
Dolasetron—Bronchospasm—Memantine—Alzheimer's disease	0.000386	0.00222	CcSEcCtD
Dolasetron—Pancreatitis—Memantine—Alzheimer's disease	0.000385	0.00222	CcSEcCtD
Dolasetron—Flatulence—Galantamine—Alzheimer's disease	0.000383	0.0022	CcSEcCtD
Dolasetron—Sweating increased—Memantine—Alzheimer's disease	0.000383	0.0022	CcSEcCtD
Dolasetron—Dysgeusia—Galantamine—Alzheimer's disease	0.000381	0.00219	CcSEcCtD
Dolasetron—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00038	0.00219	CcSEcCtD
Dolasetron—Myocardial infarction—Donepezil—Alzheimer's disease	0.000378	0.00217	CcSEcCtD
Dolasetron—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000378	0.00217	CcSEcCtD
Dolasetron—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000377	0.00217	CcSEcCtD
Dolasetron—Jaundice—Donepezil—Alzheimer's disease	0.000376	0.00216	CcSEcCtD
Dolasetron—Sweating increased—Rivastigmine—Alzheimer's disease	0.000374	0.00215	CcSEcCtD
Dolasetron—Haematuria—Donepezil—Alzheimer's disease	0.000368	0.00212	CcSEcCtD
Dolasetron—Dysuria—Memantine—Alzheimer's disease	0.000367	0.00211	CcSEcCtD
Dolasetron—Tremor—Galantamine—Alzheimer's disease	0.000364	0.0021	CcSEcCtD
Dolasetron—Epistaxis—Donepezil—Alzheimer's disease	0.000364	0.00209	CcSEcCtD
Dolasetron—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000361	0.00208	CcSEcCtD
Dolasetron—Anaemia—Galantamine—Alzheimer's disease	0.00036	0.00207	CcSEcCtD
Dolasetron—Dysuria—Rivastigmine—Alzheimer's disease	0.000359	0.00207	CcSEcCtD
Dolasetron—Agitation—Galantamine—Alzheimer's disease	0.000357	0.00206	CcSEcCtD
Dolasetron—Bradycardia—Donepezil—Alzheimer's disease	0.000353	0.00203	CcSEcCtD
Dolasetron—Pneumonia—Memantine—Alzheimer's disease	0.000352	0.00203	CcSEcCtD
Dolasetron—Malaise—Galantamine—Alzheimer's disease	0.000351	0.00202	CcSEcCtD
Dolasetron—Vertigo—Galantamine—Alzheimer's disease	0.00035	0.00201	CcSEcCtD
Dolasetron—Syncope—Galantamine—Alzheimer's disease	0.000349	0.00201	CcSEcCtD
Dolasetron—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000345	0.00199	CcSEcCtD
Dolasetron—Pneumonia—Rivastigmine—Alzheimer's disease	0.000345	0.00198	CcSEcCtD
Dolasetron—Palpitations—Galantamine—Alzheimer's disease	0.000344	0.00198	CcSEcCtD
Dolasetron—Myocardial infarction—Memantine—Alzheimer's disease	0.000343	0.00197	CcSEcCtD
Dolasetron—Drowsiness—Rivastigmine—Alzheimer's disease	0.000343	0.00197	CcSEcCtD
Dolasetron—Loss of consciousness—Galantamine—Alzheimer's disease	0.000342	0.00197	CcSEcCtD
Dolasetron—Oedema peripheral—Donepezil—Alzheimer's disease	0.000341	0.00196	CcSEcCtD
Dolasetron—Cough—Galantamine—Alzheimer's disease	0.000339	0.00195	CcSEcCtD
Dolasetron—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000338	0.00194	CcSEcCtD
Dolasetron—Convulsion—Galantamine—Alzheimer's disease	0.000337	0.00194	CcSEcCtD
Dolasetron—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000336	0.00193	CcSEcCtD
Dolasetron—Hypertension—Galantamine—Alzheimer's disease	0.000336	0.00193	CcSEcCtD
Dolasetron—Haematuria—Memantine—Alzheimer's disease	0.000334	0.00192	CcSEcCtD
Dolasetron—Visual impairment—Donepezil—Alzheimer's disease	0.000334	0.00192	CcSEcCtD
Dolasetron—Chest pain—Galantamine—Alzheimer's disease	0.000331	0.0019	CcSEcCtD
Dolasetron—Myalgia—Galantamine—Alzheimer's disease	0.000331	0.0019	CcSEcCtD
Dolasetron—Arthralgia—Galantamine—Alzheimer's disease	0.000331	0.0019	CcSEcCtD
Dolasetron—Epistaxis—Memantine—Alzheimer's disease	0.00033	0.0019	CcSEcCtD
Dolasetron—Anxiety—Galantamine—Alzheimer's disease	0.00033	0.0019	CcSEcCtD
Dolasetron—Discomfort—Galantamine—Alzheimer's disease	0.000327	0.00188	CcSEcCtD
Dolasetron—Haematuria—Rivastigmine—Alzheimer's disease	0.000327	0.00188	CcSEcCtD
Dolasetron—Dry mouth—Galantamine—Alzheimer's disease	0.000324	0.00186	CcSEcCtD
Dolasetron—Epistaxis—Rivastigmine—Alzheimer's disease	0.000323	0.00186	CcSEcCtD
Dolasetron—Tinnitus—Donepezil—Alzheimer's disease	0.000323	0.00186	CcSEcCtD
Dolasetron—Confusional state—Galantamine—Alzheimer's disease	0.00032	0.00184	CcSEcCtD
Dolasetron—Bradycardia—Memantine—Alzheimer's disease	0.00032	0.00184	CcSEcCtD
Dolasetron—Bradycardia—Rivastigmine—Alzheimer's disease	0.000313	0.0018	CcSEcCtD
Dolasetron—Shock—Galantamine—Alzheimer's disease	0.000312	0.0018	CcSEcCtD
Dolasetron—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000311	0.00179	CcSEcCtD
Dolasetron—Chills—Donepezil—Alzheimer's disease	0.000311	0.00179	CcSEcCtD
Dolasetron—Tachycardia—Galantamine—Alzheimer's disease	0.00031	0.00178	CcSEcCtD
Dolasetron—Oedema peripheral—Memantine—Alzheimer's disease	0.00031	0.00178	CcSEcCtD
Dolasetron—Arrhythmia—Donepezil—Alzheimer's disease	0.000309	0.00178	CcSEcCtD
Dolasetron—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000307	0.00177	CcSEcCtD
Dolasetron—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000303	0.00174	CcSEcCtD
Dolasetron—Visual impairment—Memantine—Alzheimer's disease	0.000303	0.00174	CcSEcCtD
Dolasetron—Anorexia—Galantamine—Alzheimer's disease	0.000303	0.00174	CcSEcCtD
Dolasetron—Flatulence—Donepezil—Alzheimer's disease	0.000297	0.00171	CcSEcCtD
Dolasetron—Hypotension—Galantamine—Alzheimer's disease	0.000297	0.00171	CcSEcCtD
Dolasetron—Visual impairment—Rivastigmine—Alzheimer's disease	0.000296	0.0017	CcSEcCtD
Dolasetron—Dysgeusia—Donepezil—Alzheimer's disease	0.000295	0.0017	CcSEcCtD
Dolasetron—Tinnitus—Memantine—Alzheimer's disease	0.000293	0.00169	CcSEcCtD
Dolasetron—Flushing—Memantine—Alzheimer's disease	0.000292	0.00168	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000289	0.00166	CcSEcCtD
Dolasetron—Tinnitus—Rivastigmine—Alzheimer's disease	0.000287	0.00165	CcSEcCtD
Dolasetron—Flushing—Rivastigmine—Alzheimer's disease	0.000286	0.00164	CcSEcCtD
Dolasetron—Paraesthesia—Galantamine—Alzheimer's disease	0.000285	0.00164	CcSEcCtD
Dolasetron—Tremor—Donepezil—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dolasetron—Somnolence—Galantamine—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dolasetron—Chills—Memantine—Alzheimer's disease	0.000282	0.00162	CcSEcCtD
Dolasetron—Arrhythmia—Memantine—Alzheimer's disease	0.000281	0.00162	CcSEcCtD
Dolasetron—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00028	0.00161	CcSEcCtD
Dolasetron—Dyspepsia—Galantamine—Alzheimer's disease	0.000279	0.00161	CcSEcCtD
Dolasetron—Anaemia—Donepezil—Alzheimer's disease	0.000279	0.0016	CcSEcCtD
Dolasetron—Agitation—Donepezil—Alzheimer's disease	0.000277	0.00159	CcSEcCtD
Dolasetron—Chills—Rivastigmine—Alzheimer's disease	0.000276	0.00159	CcSEcCtD
Dolasetron—Decreased appetite—Galantamine—Alzheimer's disease	0.000276	0.00159	CcSEcCtD
Dolasetron—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000275	0.00158	CcSEcCtD
Dolasetron—Fatigue—Galantamine—Alzheimer's disease	0.000274	0.00157	CcSEcCtD
Dolasetron—Malaise—Donepezil—Alzheimer's disease	0.000272	0.00156	CcSEcCtD
Dolasetron—Constipation—Galantamine—Alzheimer's disease	0.000272	0.00156	CcSEcCtD
Dolasetron—Vertigo—Donepezil—Alzheimer's disease	0.000271	0.00156	CcSEcCtD
Dolasetron—Syncope—Donepezil—Alzheimer's disease	0.00027	0.00155	CcSEcCtD
Dolasetron—Flatulence—Memantine—Alzheimer's disease	0.00027	0.00155	CcSEcCtD
Dolasetron—Dysgeusia—Memantine—Alzheimer's disease	0.000268	0.00154	CcSEcCtD
Dolasetron—Loss of consciousness—Donepezil—Alzheimer's disease	0.000265	0.00152	CcSEcCtD
Dolasetron—Flatulence—Rivastigmine—Alzheimer's disease	0.000264	0.00152	CcSEcCtD
Dolasetron—Cough—Donepezil—Alzheimer's disease	0.000263	0.00151	CcSEcCtD
Dolasetron—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000262	0.00151	CcSEcCtD
Dolasetron—Feeling abnormal—Galantamine—Alzheimer's disease	0.000262	0.0015	CcSEcCtD
Dolasetron—Convulsion—Donepezil—Alzheimer's disease	0.000261	0.0015	CcSEcCtD
Dolasetron—Hypertension—Donepezil—Alzheimer's disease	0.00026	0.0015	CcSEcCtD
Dolasetron—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00026	0.00149	CcSEcCtD
Dolasetron—Arthralgia—Donepezil—Alzheimer's disease	0.000257	0.00148	CcSEcCtD
Dolasetron—Chest pain—Donepezil—Alzheimer's disease	0.000257	0.00148	CcSEcCtD
Dolasetron—Myalgia—Donepezil—Alzheimer's disease	0.000257	0.00148	CcSEcCtD
Dolasetron—Tremor—Memantine—Alzheimer's disease	0.000256	0.00147	CcSEcCtD
Dolasetron—Anxiety—Donepezil—Alzheimer's disease	0.000256	0.00147	CcSEcCtD
Dolasetron—Ill-defined disorder—Memantine—Alzheimer's disease	0.000254	0.00146	CcSEcCtD
Dolasetron—Discomfort—Donepezil—Alzheimer's disease	0.000254	0.00146	CcSEcCtD
Dolasetron—Anaemia—Memantine—Alzheimer's disease	0.000253	0.00145	CcSEcCtD
Dolasetron—Agitation—Memantine—Alzheimer's disease	0.000252	0.00145	CcSEcCtD
Dolasetron—Dry mouth—Donepezil—Alzheimer's disease	0.000251	0.00144	CcSEcCtD
Dolasetron—Body temperature increased—Galantamine—Alzheimer's disease	0.000251	0.00144	CcSEcCtD
Dolasetron—Abdominal pain—Galantamine—Alzheimer's disease	0.000251	0.00144	CcSEcCtD
Dolasetron—Tremor—Rivastigmine—Alzheimer's disease	0.000251	0.00144	CcSEcCtD
Dolasetron—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000248	0.00143	CcSEcCtD
Dolasetron—Confusional state—Donepezil—Alzheimer's disease	0.000248	0.00143	CcSEcCtD
Dolasetron—Anaemia—Rivastigmine—Alzheimer's disease	0.000248	0.00142	CcSEcCtD
Dolasetron—Malaise—Memantine—Alzheimer's disease	0.000247	0.00142	CcSEcCtD
Dolasetron—Agitation—Rivastigmine—Alzheimer's disease	0.000246	0.00142	CcSEcCtD
Dolasetron—Oedema—Donepezil—Alzheimer's disease	0.000246	0.00141	CcSEcCtD
Dolasetron—Vertigo—Memantine—Alzheimer's disease	0.000246	0.00141	CcSEcCtD
Dolasetron—Syncope—Memantine—Alzheimer's disease	0.000245	0.00141	CcSEcCtD
Dolasetron—Shock—Donepezil—Alzheimer's disease	0.000242	0.00139	CcSEcCtD
Dolasetron—Palpitations—Memantine—Alzheimer's disease	0.000242	0.00139	CcSEcCtD
Dolasetron—Malaise—Rivastigmine—Alzheimer's disease	0.000241	0.00139	CcSEcCtD
Dolasetron—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000241	0.00139	CcSEcCtD
Dolasetron—Vertigo—Rivastigmine—Alzheimer's disease	0.000241	0.00138	CcSEcCtD
Dolasetron—Loss of consciousness—Memantine—Alzheimer's disease	0.000241	0.00138	CcSEcCtD
Dolasetron—Syncope—Rivastigmine—Alzheimer's disease	0.00024	0.00138	CcSEcCtD
Dolasetron—Cough—Memantine—Alzheimer's disease	0.000239	0.00137	CcSEcCtD
Dolasetron—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000238	0.00137	CcSEcCtD
Dolasetron—Convulsion—Memantine—Alzheimer's disease	0.000237	0.00136	CcSEcCtD
Dolasetron—Palpitations—Rivastigmine—Alzheimer's disease	0.000237	0.00136	CcSEcCtD
Dolasetron—Hypertension—Memantine—Alzheimer's disease	0.000236	0.00136	CcSEcCtD
Dolasetron—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000235	0.00135	CcSEcCtD
Dolasetron—Anorexia—Donepezil—Alzheimer's disease	0.000235	0.00135	CcSEcCtD
Dolasetron—Hypersensitivity—Galantamine—Alzheimer's disease	0.000234	0.00135	CcSEcCtD
Dolasetron—Cough—Rivastigmine—Alzheimer's disease	0.000234	0.00134	CcSEcCtD
Dolasetron—Arthralgia—Memantine—Alzheimer's disease	0.000233	0.00134	CcSEcCtD
Dolasetron—Myalgia—Memantine—Alzheimer's disease	0.000233	0.00134	CcSEcCtD
Dolasetron—Chest pain—Memantine—Alzheimer's disease	0.000233	0.00134	CcSEcCtD
Dolasetron—Anxiety—Memantine—Alzheimer's disease	0.000232	0.00134	CcSEcCtD
Dolasetron—Convulsion—Rivastigmine—Alzheimer's disease	0.000232	0.00133	CcSEcCtD
Dolasetron—Hypertension—Rivastigmine—Alzheimer's disease	0.000231	0.00133	CcSEcCtD
Dolasetron—Discomfort—Memantine—Alzheimer's disease	0.00023	0.00132	CcSEcCtD
Dolasetron—Hypotension—Donepezil—Alzheimer's disease	0.00023	0.00132	CcSEcCtD
Dolasetron—Arthralgia—Rivastigmine—Alzheimer's disease	0.000228	0.00131	CcSEcCtD
Dolasetron—Chest pain—Rivastigmine—Alzheimer's disease	0.000228	0.00131	CcSEcCtD
Dolasetron—Myalgia—Rivastigmine—Alzheimer's disease	0.000228	0.00131	CcSEcCtD
Dolasetron—Dry mouth—Memantine—Alzheimer's disease	0.000228	0.00131	CcSEcCtD
Dolasetron—Asthenia—Galantamine—Alzheimer's disease	0.000228	0.00131	CcSEcCtD
Dolasetron—Anxiety—Rivastigmine—Alzheimer's disease	0.000227	0.00131	CcSEcCtD
Dolasetron—Confusional state—Memantine—Alzheimer's disease	0.000225	0.0013	CcSEcCtD
Dolasetron—Discomfort—Rivastigmine—Alzheimer's disease	0.000225	0.0013	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000224	0.00129	CcSEcCtD
Dolasetron—Oedema—Memantine—Alzheimer's disease	0.000223	0.00128	CcSEcCtD
Dolasetron—Dry mouth—Rivastigmine—Alzheimer's disease	0.000223	0.00128	CcSEcCtD
Dolasetron—Paraesthesia—Donepezil—Alzheimer's disease	0.000221	0.00127	CcSEcCtD
Dolasetron—Confusional state—Rivastigmine—Alzheimer's disease	0.00022	0.00127	CcSEcCtD
Dolasetron—Shock—Memantine—Alzheimer's disease	0.00022	0.00126	CcSEcCtD
Dolasetron—Dyspnoea—Donepezil—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dolasetron—Somnolence—Donepezil—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dolasetron—Thrombocytopenia—Memantine—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dolasetron—Oedema—Rivastigmine—Alzheimer's disease	0.000219	0.00126	CcSEcCtD
Dolasetron—Tachycardia—Memantine—Alzheimer's disease	0.000218	0.00125	CcSEcCtD
Dolasetron—Diarrhoea—Galantamine—Alzheimer's disease	0.000217	0.00125	CcSEcCtD
Dolasetron—Dyspepsia—Donepezil—Alzheimer's disease	0.000217	0.00125	CcSEcCtD
Dolasetron—Hyperhidrosis—Memantine—Alzheimer's disease	0.000216	0.00124	CcSEcCtD
Dolasetron—Shock—Rivastigmine—Alzheimer's disease	0.000215	0.00124	CcSEcCtD
Dolasetron—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000214	0.00123	CcSEcCtD
Dolasetron—Decreased appetite—Donepezil—Alzheimer's disease	0.000214	0.00123	CcSEcCtD
Dolasetron—Tachycardia—Rivastigmine—Alzheimer's disease	0.000213	0.00123	CcSEcCtD
Dolasetron—Anorexia—Memantine—Alzheimer's disease	0.000213	0.00122	CcSEcCtD
Dolasetron—Fatigue—Donepezil—Alzheimer's disease	0.000212	0.00122	CcSEcCtD
Dolasetron—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000211	0.00122	CcSEcCtD
Dolasetron—Pain—Donepezil—Alzheimer's disease	0.00021	0.00121	CcSEcCtD
Dolasetron—Constipation—Donepezil—Alzheimer's disease	0.00021	0.00121	CcSEcCtD
Dolasetron—Dizziness—Galantamine—Alzheimer's disease	0.00021	0.00121	CcSEcCtD
Dolasetron—Hypotension—Memantine—Alzheimer's disease	0.000209	0.0012	CcSEcCtD
Dolasetron—Anorexia—Rivastigmine—Alzheimer's disease	0.000208	0.0012	CcSEcCtD
Dolasetron—Hypotension—Rivastigmine—Alzheimer's disease	0.000204	0.00117	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000204	0.00117	CcSEcCtD
Dolasetron—Feeling abnormal—Donepezil—Alzheimer's disease	0.000203	0.00117	CcSEcCtD
Dolasetron—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000201	0.00116	CcSEcCtD
Dolasetron—Paraesthesia—Memantine—Alzheimer's disease	0.000201	0.00115	CcSEcCtD
Dolasetron—Rash—Galantamine—Alzheimer's disease	0.0002	0.00115	CcSEcCtD
Dolasetron—Dermatitis—Galantamine—Alzheimer's disease	0.0002	0.00115	CcSEcCtD
Dolasetron—Dyspnoea—Memantine—Alzheimer's disease	0.000199	0.00115	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000199	0.00115	CcSEcCtD
Dolasetron—Headache—Galantamine—Alzheimer's disease	0.000199	0.00114	CcSEcCtD
Dolasetron—Somnolence—Memantine—Alzheimer's disease	0.000199	0.00114	CcSEcCtD
Dolasetron—Dyspepsia—Memantine—Alzheimer's disease	0.000197	0.00113	CcSEcCtD
Dolasetron—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000196	0.00113	CcSEcCtD
Dolasetron—Urticaria—Donepezil—Alzheimer's disease	0.000195	0.00112	CcSEcCtD
Dolasetron—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000195	0.00112	CcSEcCtD
Dolasetron—Body temperature increased—Donepezil—Alzheimer's disease	0.000195	0.00112	CcSEcCtD
Dolasetron—Abdominal pain—Donepezil—Alzheimer's disease	0.000195	0.00112	CcSEcCtD
Dolasetron—Somnolence—Rivastigmine—Alzheimer's disease	0.000194	0.00112	CcSEcCtD
Dolasetron—Decreased appetite—Memantine—Alzheimer's disease	0.000194	0.00112	CcSEcCtD
Dolasetron—Fatigue—Memantine—Alzheimer's disease	0.000193	0.00111	CcSEcCtD
Dolasetron—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000192	0.00111	CcSEcCtD
Dolasetron—Pain—Memantine—Alzheimer's disease	0.000191	0.0011	CcSEcCtD
Dolasetron—Constipation—Memantine—Alzheimer's disease	0.000191	0.0011	CcSEcCtD
Dolasetron—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00019	0.00109	CcSEcCtD
Dolasetron—Fatigue—Rivastigmine—Alzheimer's disease	0.000188	0.00108	CcSEcCtD
Dolasetron—Pain—Rivastigmine—Alzheimer's disease	0.000187	0.00107	CcSEcCtD
Dolasetron—Constipation—Rivastigmine—Alzheimer's disease	0.000187	0.00107	CcSEcCtD
Dolasetron—Feeling abnormal—Memantine—Alzheimer's disease	0.000184	0.00106	CcSEcCtD
Dolasetron—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000183	0.00105	CcSEcCtD
Dolasetron—Hypersensitivity—Donepezil—Alzheimer's disease	0.000181	0.00104	CcSEcCtD
Dolasetron—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00018	0.00104	CcSEcCtD
Dolasetron—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000179	0.00103	CcSEcCtD
Dolasetron—Urticaria—Memantine—Alzheimer's disease	0.000177	0.00102	CcSEcCtD
Dolasetron—Abdominal pain—Memantine—Alzheimer's disease	0.000177	0.00102	CcSEcCtD
Dolasetron—Body temperature increased—Memantine—Alzheimer's disease	0.000177	0.00102	CcSEcCtD
Dolasetron—Asthenia—Donepezil—Alzheimer's disease	0.000177	0.00102	CcSEcCtD
Dolasetron—Pruritus—Donepezil—Alzheimer's disease	0.000174	0.001	CcSEcCtD
Dolasetron—Urticaria—Rivastigmine—Alzheimer's disease	0.000174	0.000998	CcSEcCtD
Dolasetron—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000173	0.000994	CcSEcCtD
Dolasetron—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000173	0.000994	CcSEcCtD
Dolasetron—Diarrhoea—Donepezil—Alzheimer's disease	0.000168	0.000968	CcSEcCtD
Dolasetron—Hypersensitivity—Memantine—Alzheimer's disease	0.000165	0.000947	CcSEcCtD
Dolasetron—Dizziness—Donepezil—Alzheimer's disease	0.000163	0.000936	CcSEcCtD
Dolasetron—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000161	0.000926	CcSEcCtD
Dolasetron—Asthenia—Memantine—Alzheimer's disease	0.00016	0.000922	CcSEcCtD
Dolasetron—Pruritus—Memantine—Alzheimer's disease	0.000158	0.000909	CcSEcCtD
Dolasetron—Asthenia—Rivastigmine—Alzheimer's disease	0.000157	0.000902	CcSEcCtD
Dolasetron—Rash—Donepezil—Alzheimer's disease	0.000155	0.000892	CcSEcCtD
Dolasetron—Dermatitis—Donepezil—Alzheimer's disease	0.000155	0.000891	CcSEcCtD
Dolasetron—Pruritus—Rivastigmine—Alzheimer's disease	0.000155	0.000889	CcSEcCtD
Dolasetron—Headache—Donepezil—Alzheimer's disease	0.000154	0.000886	CcSEcCtD
Dolasetron—Diarrhoea—Memantine—Alzheimer's disease	0.000153	0.000879	CcSEcCtD
Dolasetron—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00015	0.00086	CcSEcCtD
Dolasetron—Dizziness—Memantine—Alzheimer's disease	0.000148	0.00085	CcSEcCtD
Dolasetron—Dizziness—Rivastigmine—Alzheimer's disease	0.000145	0.000831	CcSEcCtD
Dolasetron—Rash—Memantine—Alzheimer's disease	0.000141	0.00081	CcSEcCtD
Dolasetron—Dermatitis—Memantine—Alzheimer's disease	0.000141	0.000809	CcSEcCtD
Dolasetron—Headache—Memantine—Alzheimer's disease	0.00014	0.000805	CcSEcCtD
Dolasetron—Rash—Rivastigmine—Alzheimer's disease	0.000138	0.000792	CcSEcCtD
Dolasetron—Dermatitis—Rivastigmine—Alzheimer's disease	0.000138	0.000792	CcSEcCtD
Dolasetron—Headache—Rivastigmine—Alzheimer's disease	0.000137	0.000787	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	6.52e-05	0.0266	CbGpPWpGaD
Dolasetron—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	6.18e-05	0.0252	CbGpPWpGaD
Dolasetron—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	5.73e-05	0.0234	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—MAP2—Alzheimer's disease	5.58e-05	0.0227	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	5.54e-05	0.0226	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	5.54e-05	0.0226	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	5.37e-05	0.0219	CbGpPWpGaD
Dolasetron—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	5.26e-05	0.0214	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	4.71e-05	0.0192	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	4.43e-05	0.0181	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	4.39e-05	0.0179	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	4.35e-05	0.0177	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	4.3e-05	0.0175	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	3.98e-05	0.0162	CbGpPWpGaD
Dolasetron—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	3.83e-05	0.0156	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	3.83e-05	0.0156	CbGpPWpGaD
Dolasetron—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	3.78e-05	0.0154	CbGpPWpGaD
Dolasetron—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	3.69e-05	0.015	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	3.62e-05	0.0148	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	3.61e-05	0.0147	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	3.59e-05	0.0146	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	3.57e-05	0.0146	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TF—Alzheimer's disease	3.57e-05	0.0146	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	3.54e-05	0.0144	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	3.36e-05	0.0137	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—SST—Alzheimer's disease	3.27e-05	0.0133	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	3.27e-05	0.0133	CbGpPWpGaD
Dolasetron—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	3.19e-05	0.013	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	3.13e-05	0.0127	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	3.04e-05	0.0124	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	3.02e-05	0.0123	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	2.94e-05	0.012	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	2.91e-05	0.0119	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	2.66e-05	0.0108	CbGpPWpGaD
Dolasetron—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	2.53e-05	0.0103	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	2.51e-05	0.0102	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	2.44e-05	0.00993	CbGpPWpGaD
Dolasetron—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	2.43e-05	0.00991	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	2.37e-05	0.00965	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	2.34e-05	0.00954	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	2.34e-05	0.00952	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	2.26e-05	0.00923	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—APOD—Alzheimer's disease	2.26e-05	0.0092	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	2.17e-05	0.00886	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	2.16e-05	0.00882	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	2.06e-05	0.00839	CbGpPWpGaD
Dolasetron—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	1.97e-05	0.00802	CbGpPWpGaD
Dolasetron—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	1.97e-05	0.00802	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	1.92e-05	0.00782	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	1.88e-05	0.00765	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	1.75e-05	0.00714	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	1.75e-05	0.00712	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	1.74e-05	0.00708	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	1.64e-05	0.0067	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	1.64e-05	0.0067	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	1.64e-05	0.00668	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	1.59e-05	0.00649	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	1.57e-05	0.0064	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	1.56e-05	0.00635	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	1.55e-05	0.0063	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	1.54e-05	0.00627	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	1.52e-05	0.00621	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	1.43e-05	0.00584	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	1.42e-05	0.00578	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.42e-05	0.00578	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	1.33e-05	0.00541	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	1.32e-05	0.00536	CbGpPWpGaD
Dolasetron—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	1.3e-05	0.00529	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	1.29e-05	0.00526	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	1.25e-05	0.00508	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.22e-05	0.00497	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.22e-05	0.00496	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.21e-05	0.00491	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	1.15e-05	0.00467	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	1.05e-05	0.00428	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	1.04e-05	0.00422	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.03e-05	0.00421	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	1.02e-05	0.00415	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	1.01e-05	0.0041	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	9.3e-06	0.00379	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	9.22e-06	0.00376	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	8.9e-06	0.00363	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	8.86e-06	0.00361	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	8.68e-06	0.00354	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	8.51e-06	0.00347	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.43e-06	0.00344	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	8.21e-06	0.00335	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	7.2e-06	0.00293	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	7.15e-06	0.00291	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	7.05e-06	0.00287	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	6.99e-06	0.00285	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	6.85e-06	0.00279	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	6.76e-06	0.00276	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	6.43e-06	0.00262	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6.08e-06	0.00248	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	5.94e-06	0.00242	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.61e-06	0.00188	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.52e-06	0.00184	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.46e-06	0.00182	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	4e-06	0.00163	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	3.96e-06	0.00161	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.69e-06	0.00151	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CA4—Alzheimer's disease	3.4e-06	0.00138	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CA4—Alzheimer's disease	3.37e-06	0.00137	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.29e-06	0.00134	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	3.19e-06	0.0013	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	3.17e-06	0.00129	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	3.03e-06	0.00123	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	3e-06	0.00122	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.89e-06	0.00118	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.86e-06	0.00117	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.86e-06	0.00117	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.83e-06	0.00115	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	2.77e-06	0.00113	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.75e-06	0.00112	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.68e-06	0.00109	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.67e-06	0.00109	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.64e-06	0.00108	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.61e-06	0.00106	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ND1—Alzheimer's disease	2.58e-06	0.00105	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ND1—Alzheimer's disease	2.55e-06	0.00104	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.5e-06	0.00102	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.28e-06	0.00093	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.22e-06	0.000905	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.09e-06	0.000851	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.98e-06	0.000807	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.97e-06	0.000802	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.89e-06	0.00077	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.81e-06	0.000738	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.79e-06	0.00073	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.74e-06	0.000711	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.68e-06	0.000686	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.66e-06	0.000676	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.66e-06	0.000676	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.65e-06	0.000671	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.65e-06	0.000671	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.59e-06	0.000648	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.58e-06	0.000643	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.53e-06	0.000624	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.52e-06	0.000619	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.5e-06	0.000612	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.49e-06	0.000606	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.48e-06	0.000603	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.47e-06	0.000598	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.31e-06	0.000533	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.29e-06	0.000524	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.28e-06	0.00052	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.27e-06	0.000518	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.26e-06	0.000514	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.21e-06	0.000491	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.21e-06	0.000491	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.2e-06	0.000487	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.2e-06	0.000487	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.17e-06	0.000478	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.12e-06	0.000457	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.11e-06	0.000453	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.08e-06	0.000442	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.08e-06	0.000442	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	1.06e-06	0.000431	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.05e-06	0.000427	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.04e-06	0.000424	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.03e-06	0.000419	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	1.03e-06	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.02e-06	0.000414	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1e-06	0.000408	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—A2M—Alzheimer's disease	9.67e-07	0.000394	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	8.84e-07	0.00036	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	8.8e-07	0.000359	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	8.76e-07	0.000357	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	8.72e-07	0.000355	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ACHE—Alzheimer's disease	8.41e-07	0.000343	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	8.32e-07	0.000339	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPL—Alzheimer's disease	8.05e-07	0.000328	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPL—Alzheimer's disease	7.98e-07	0.000325	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ENO1—Alzheimer's disease	7.88e-07	0.000321	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	7.88e-07	0.000321	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.73e-07	0.000315	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—BCHE—Alzheimer's disease	7.33e-07	0.000299	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	7.24e-07	0.000295	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	7.18e-07	0.000293	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.92e-07	0.000282	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CALM1—Alzheimer's disease	6.77e-07	0.000276	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOE—Alzheimer's disease	6.74e-07	0.000275	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CALM1—Alzheimer's disease	6.71e-07	0.000273	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.7e-07	0.000273	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOE—Alzheimer's disease	6.69e-07	0.000272	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAV1—Alzheimer's disease	6.68e-07	0.000272	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAV1—Alzheimer's disease	6.62e-07	0.00027	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARG—Alzheimer's disease	5.87e-07	0.000239	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARG—Alzheimer's disease	5.82e-07	0.000237	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.78e-07	0.000235	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—INS—Alzheimer's disease	5.76e-07	0.000235	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.75e-07	0.000234	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—INS—Alzheimer's disease	5.71e-07	0.000233	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.26e-07	0.000214	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NOS3—Alzheimer's disease	5.05e-07	0.000206	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NOS3—Alzheimer's disease	5.01e-07	0.000204	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.74e-07	0.000193	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	4.62e-07	0.000188	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	4.58e-07	0.000187	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.42e-07	0.00018	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.41e-07	0.00018	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.37e-07	0.000178	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.84e-07	0.000157	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—INS—Alzheimer's disease	3.77e-07	0.000154	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.3e-07	0.000135	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.02e-07	0.000123	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—Alzheimer's disease	2.32e-07	9.47e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.3e-07	9.38e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.52e-07	6.19e-05	CbGpPWpGaD
